This randomized controlled trial evaluated the cost-utility of a multidisciplinary telemedicine program added to standard care for fall prevention in Parkinson’s disease, finding that while total and direct costs were higher in the telemedicine group, the intervention was efficient in improving non-motor symptoms, gait, balance, frailty, and quality of life. The study concluded that telemedicine is a cost-effective complementary strategy for managing Parkinson’s disease, particularly for enhancing access and outcomes in non-motor domains.
Esther Cubo, Mohammad Rohani, Negin Eissazade, Álvaro García‐Bustillo, José Miguel Ramírez‐Sanz, José Luis Garrido-Labrador, Alicia Olivares‐Gil, Florita Valiñas‐Sieiro Rn, Marta Allende‐Río Rn, Josefa Gonzalez‐Santos, Jerónimo Javier Gonzalez‐Bernal, Jose Trejo, Sara Calvo‐Simal, José Francisco Diez‐Pastor, David García‐García, Álvar Arnaiz‐González